Magnetic resonance spectroscopy, positron emission tomography and radiogenomics-Relevance to glioma

Gloria C. Chiang; Ilhami Kovanlikaya; Changho Choi; Rohan Ramakrishna; Rajiv Magge; Dikoma C. Shungu

doi:10.3389/fneur.2018.00033

Magnetic resonance spectroscopy, positron emission tomography and radiogenomics-Relevance to glioma

Gloria C. Chiang, Ilhami Kovanlikaya, Changho Choi, Rohan Ramakrishna, Rajiv Magge, Dikoma C. Shungu

Research output: Contribution to journal › Short survey › peer-review

34 Scopus citations

Abstract

Advances in metabolic imaging techniques have allowed for more precise characterization of gliomas, particularly as it relates to tumor recurrence or pseudoprogression. Furthermore, the emerging field of radiogenomics where radiographic features are systemically correlated with molecular markers has the potential to achieve the holy grail of neuro-oncologic neuro-radiology, namely molecular diagnosis without requiring tissue specimens. In this section, we will review the utility of metabolic imaging and discuss the current state of the art related to the radiogenomics of glioblastoma.

Original language	English (US)
Article number	33
Journal	Frontiers in Neurology
Volume	9
Issue number	FEB
DOIs	https://doi.org/10.3389/fneur.2018.00033
State	Published - Feb 5 2018

Keywords

Glioma
Magnetic resonance spectroscopy
Neurooncology
Neuroradiology
Positron-emission tomography
Radiogenomics

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.3389/fneur.2018.00033

Cite this

@article{398c5b834d6a4a4f85e4db9959f2c3c9,

title = "Magnetic resonance spectroscopy, positron emission tomography and radiogenomics-Relevance to glioma",

abstract = "Advances in metabolic imaging techniques have allowed for more precise characterization of gliomas, particularly as it relates to tumor recurrence or pseudoprogression. Furthermore, the emerging field of radiogenomics where radiographic features are systemically correlated with molecular markers has the potential to achieve the holy grail of neuro-oncologic neuro-radiology, namely molecular diagnosis without requiring tissue specimens. In this section, we will review the utility of metabolic imaging and discuss the current state of the art related to the radiogenomics of glioblastoma.",

keywords = "Glioma, Magnetic resonance spectroscopy, Neurooncology, Neuroradiology, Positron-emission tomography, Radiogenomics",

author = "Chiang, {Gloria C.} and Ilhami Kovanlikaya and Changho Choi and Rohan Ramakrishna and Rajiv Magge and Shungu, {Dikoma C.}",

note = "Publisher Copyright: {\textcopyright} 2018 Chiang, Kovanlikaya, Choi, Ramakrishna, Magge and Shungu.",

year = "2018",

month = feb,

day = "5",

doi = "10.3389/fneur.2018.00033",

language = "English (US)",

volume = "9",

journal = "Frontiers in Neurology",

issn = "1664-2295",

publisher = "Frontiers Research Foundation",

number = "FEB",

}

TY - JOUR

T1 - Magnetic resonance spectroscopy, positron emission tomography and radiogenomics-Relevance to glioma

AU - Chiang, Gloria C.

AU - Kovanlikaya, Ilhami

AU - Choi, Changho

AU - Ramakrishna, Rohan

AU - Magge, Rajiv

AU - Shungu, Dikoma C.

PY - 2018/2/5

Y1 - 2018/2/5

N2 - Advances in metabolic imaging techniques have allowed for more precise characterization of gliomas, particularly as it relates to tumor recurrence or pseudoprogression. Furthermore, the emerging field of radiogenomics where radiographic features are systemically correlated with molecular markers has the potential to achieve the holy grail of neuro-oncologic neuro-radiology, namely molecular diagnosis without requiring tissue specimens. In this section, we will review the utility of metabolic imaging and discuss the current state of the art related to the radiogenomics of glioblastoma.

AB - Advances in metabolic imaging techniques have allowed for more precise characterization of gliomas, particularly as it relates to tumor recurrence or pseudoprogression. Furthermore, the emerging field of radiogenomics where radiographic features are systemically correlated with molecular markers has the potential to achieve the holy grail of neuro-oncologic neuro-radiology, namely molecular diagnosis without requiring tissue specimens. In this section, we will review the utility of metabolic imaging and discuss the current state of the art related to the radiogenomics of glioblastoma.

KW - Glioma

KW - Magnetic resonance spectroscopy

KW - Neurooncology

KW - Neuroradiology

KW - Positron-emission tomography

KW - Radiogenomics

UR - http://www.scopus.com/inward/record.url?scp=85041830619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041830619&partnerID=8YFLogxK

U2 - 10.3389/fneur.2018.00033

DO - 10.3389/fneur.2018.00033

M3 - Short survey

C2 - 29459844

AN - SCOPUS:85041830619

SN - 1664-2295

VL - 9

JO - Frontiers in Neurology

JF - Frontiers in Neurology

IS - FEB

M1 - 33

ER -

Magnetic resonance spectroscopy, positron emission tomography and radiogenomics-Relevance to glioma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this